Final answer:
All the given options are incorrect because older adults, opiate-naïve clients, and those with underlying pulmonary disease are at higher risk for opioid-induced respiratory depression, which conflicts with the claims in the options provided.
Step-by-step explanation:
The statement provided suggests that certain populations are at heightened risk for respiratory depression when using opioids. These groups include older adult clients, those who are opiate-naïve, and clients with underlying pulmonary disease. Given this information, the adolescent mentioned, having two of these risk factors, is incorrectly represented in all of the presented statements.
Option A is incorrect because the initial statement clarifies that adolescents with opiate-naïvety and pulmonary issues are at risk. Option B is also incorrect because older adults are clearly included as at risk for respiratory depression from opioid use. The claim in Option C is false; opiate-naïve clients are actually at higher risk for respiratory depression since they have not developed tolerance. Lastly, Option D is a misconception since pulmonary disease indeed increases the risk for opioid-induced respiratory depression.
Opioid addiction and overdose are significant challenges in healthcare, particularly given the opioid epidemic and the risks associated with opioid use. The opioid crisis in America traces back to the 1990s with the mass-marketing of opioid drugs and has led to widespread misuse and addiction, which can lead to respiratory depression and death.